ALLMedicine™ Acne Vulgaris Center
Research & Reviews 1,040 results
https://doi.org/10.2174/1874467215666220520143124
Current Molecular Pharmacology; Yilmaz S
May 28th, 2022 - Acne is a chronic inflammatory disease and mainly seen in adolescence, but it can also be seen during the neonatal, infantile, pre-pubertal, and adult periods. Isotretinoin (13-cis-retinoic acid) is a first-generation retinoid and is the most effe...
https://doi.org/10.1111/jocd.15120
Journal of Cosmetic Dermatology; Vural AT
May 28th, 2022 - Recent work conducted with healthcare workers and middle-aged populations has recognized the association between acne vulgaris (AV) and mask wearing. This study aims to evaluate the correlation between the face mask and AV in a group of university...
https://doi.org/10.2174/1567201819666220524154448
Current Drug Delivery; Dudhat S, Singh P et. al.
May 26th, 2022 - Acne vulgaris is a universal multifactorial human skin condition of the pilosebaceous units. Although acne majorly prevails in teenagers, it is neither restricted to age group nor gender. Multifarious causative factors like Propionibacterium acnes...
https://doi.org/10.1080/15569527.2022.2077749
Cutaneous and Ocular Toxicology; Acar Eser N, Kocabeyoğlu S et. al.
May 25th, 2022 - To assess the effects of systemic isotretinoin therapy (SIT) on the ocular surface, meibomian glands (MG) and cornea microstructure in acne vulgaris (AV) patients. Patients with AV (n = 20) and healthy controls (n = 20) were enrolled in the study....
https://doi.org/10.1111/jocd.15107
Journal of Cosmetic Dermatology; Wang L, Wu J et. al.
May 24th, 2022 - We used high-throughput sequencing on skin microbial flora to assess the effectiveness of an acne prescription to formulate evidence for clinical decision-making. We randomised twenty outpatients into two groups. The treatment group was given the ...
Guidelines 3 results
https://doi.org/10.1136/bmj.n1800
BMJ (Clinical Research Ed.); Xu J, Mavranezouli I et. al.
Sep 22nd, 2021 - Management of acne vulgaris: summary of NICE guidance.|2021|Xu J,Mavranezouli I,Kuznetsov L,Stephen Murphy M,Healy E,|
https://doi.org/10.1111/1346-8138.14355
The Journal of Dermatology; Hayashi N, Akamatsu H et. al.
May 22nd, 2018 - The Guidelines for the Treatment of Acne Vulgaris of the Japanese Dermatological Association was first published in Japanese in 2008 and revised in 2016 and 2017. These guidelines (GL) indicate the standard acne treatments in Japan and address pha...
https://doi.org/10.1542/peds.2013-0490B
Pediatrics Eichenfield LF, Krakowski AC et. al.
May 3rd, 2013 - Acne vulgaris is one of the most common skin conditions in children and adolescents. The presentation, differential diagnosis, and association of acne with systemic pathology differs by age of presentation. Current acknowledged guidelines for the ...
Drugs 413 results see all →
Clinicaltrials.gov 116 results
https://clinicaltrials.gov/ct2/show/NCT05096312
May 11th, 2022 - Acne has four main pathogenic contributors: follicular hyperkeratinization, increased sebum production, Propionibacterium acnes (P. acnes) within the follicle, and inflammation. Treatment options for acne vulgaris include benzoyl peroxide, topical...
https://clinicaltrials.gov/ct2/show/NCT03573518
Apr 18th, 2022 - This will be a multi-center, randomized, double-blinded, vehicle-controlled, parallel group, dose-finding study in pediatrics, adolescents and adults (aged 12 to 40 years). The objective of this study is to assess the safety and efficacy of variou...
https://clinicaltrials.gov/ct2/show/NCT05301569
Mar 29th, 2022 - cross-sectional study in which participants will be recruited at dermatology & Andrology out-patient clinics in Assuit university hospital, Egypt after patients examination by dermatologists & obtaining an informed consent
https://clinicaltrials.gov/ct2/show/NCT04940767
Mar 23rd, 2022 - Acne vulgaris is a common disease of both males and females, usually manifesting initially during adolescence. The primary pathologic events are initiated in the pilosebaceous units, especially of sebaceous-gland-bearing areas of the face, chest, ...
https://clinicaltrials.gov/ct2/show/NCT04820673
Mar 18th, 2022 - The purpose of this study is to evaluate the patient-reported outcomes (PROs) in terms of health-related quality of life (HRQoL) and signs of Acne Vulgaris (AV) among patients with moderate to severe non-nodular AV who are administered sarecycline...
News 155 results
https://www.medscape.com/viewarticle/967603
Feb 17th, 2022 - Adbry (tralokinumab) Tralokinumab is an interleukin-13 (IL-13) inhibitor that blocks IL-13–induced responses (eg, release of proinflammatory cytokines, chemokines, IgE). It is indicated for moderate-to-severe atopic dermatitis in adults who are no...
https://www.mdedge.com/dermatology/article/246249/acne/acne-vulgaris
Candrice R. Heath, MD, Richard P. Usatine, MD
Sep 17th, 2021 - Photographs courtesy of Richard P. Usatine, MD.
https://www.medpagetoday.com/infectiousdisease/covid19/93781
Jul 28th, 2021 - Note that some links may require registration or subscription. Spurred on by the highly transmissible Delta variant and a flat-lined vaccination rate, the COVID-19 case count could reach 200,000 per day over the next 4-6 weeks, said former CDC dir...
https://www.mdedge.com/dermatology/article/242754/acne/results-laboratory-monitoring-patients-taking-isotretinoin-acne
Mohammed Al-Haddab, MD, FRCPC, Alanoud Alhuqayl, MD et. al.
Jul 9th, 2021 - Introduced in 1982, isotretinoin is a retinoid derivative that has been widely used to treat various dermatologic conditions such as acne vulgaris, rosacea, hidradenitis suppurativa, and hair folliculitis. 1 It remains one of the most effective dr.
https://www.medscape.com/viewarticle/953824
Jun 28th, 2021 - The National Institute for Health and Care Excellence (NICE) has recommended that individuals severely affected by acne should receive mental health support in a new guideline on the management of acne vulgaris published on 25 June 2021. An estima...